SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $100,130 | +428.6% | 3,331 | +527.3% | 0.01% | +600.0% |
Q4 2022 | $18,941 | -66.8% | 531 | -68.6% | 0.00% | -75.0% |
Q3 2022 | $57,000 | -65.2% | 1,689 | -72.7% | 0.00% | -66.7% |
Q3 2021 | $164,000 | +264.4% | 6,183 | +257.2% | 0.01% | +200.0% |
Q1 2021 | $45,000 | -76.8% | 1,731 | -68.9% | 0.00% | -77.8% |
Q1 2019 | $194,000 | +2.6% | 5,562 | -2.4% | 0.02% | -5.3% |
Q4 2018 | $189,000 | +67.3% | 5,700 | +153.1% | 0.02% | +137.5% |
Q3 2018 | $113,000 | +11.9% | 2,252 | +1.8% | 0.01% | -11.1% |
Q1 2018 | $101,000 | -65.6% | 2,212 | -70.1% | 0.01% | -66.7% |
Q4 2017 | $294,000 | +18.5% | 7,393 | +19.1% | 0.03% | +12.5% |
Q3 2017 | $248,000 | +1358.8% | 6,208 | +607.9% | 0.02% | +1100.0% |
Q2 2016 | $17,000 | -90.8% | 877 | -91.9% | 0.00% | -93.9% |
Q2 2015 | $184,000 | +2528.6% | 10,889 | +1714.8% | 0.03% | +1550.0% |
Q1 2015 | $7,000 | -85.7% | 600 | -89.2% | 0.00% | -83.3% |
Q1 2014 | $49,000 | – | 5,544 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |